A mastectomy is prudent when breast cancer returns after a lumpectomy, because survival rates are higher for those who have another lumpectomy, according to a new study published in the American Journal of Surgery in October.
The 2nd international symposium `Diabetic foot: surgery, therapy, rehabilitation´ took place on the beginning of October in St. Petersburg. Olga Ostrovskaya reports from Russia
A panel of experts, convened by the American Diabetes Association and the European Association for the Study of Diabetes, has issued updated treatment recommendations for type 2 diabetes, in a consensus statement published online in two journals: Diabetes Care and Diabetologia*.
When from 19 to 22 November the world's largest medical fair takes place in Dusseldorf, the entire city is in a kind of emergency state: hotels are bustin' out of their seams, traffic periodically comes to a standstill and at night exhibitors and visitors alike crowd the narrow streets of the Altstadt and the fancy hotel bars and enjoy whatever entertainment North Rhine-Westphalia's capital has…
Olwen Glynn Owen reports on MammaPrint, a test that pinpoints the risk of breast cancer recurrence from the primary tumour's genetic make-up. Women with breast cancer tumours under
Infusion technology has come a long way in the past decade, explains Stéphane Ruton, Director of Strategic Marketing for IV Technology at Fresenius Kabi, which focuses on infusion therapies and clinical nutrition, as well as the respective medical devices.
Als Kongresspräsident lud Professor Stefan N. Willich von der Berliner Charité zur Diskussion über die Möglichkeit, dem Wunsch der Patienten nach integrierter medizinischer Versorgung nachzukommen. Denn bei chronischen oder Herz-Kreislauf-Erkrankungen zum Beispiel möchten die Menschen sowohl schulmedizinische Aufklärung und Behandlung durch ihren Arzt als auch…
The Swiss charity EurAsia Heart, founded in 2006 by cardiac surgeon Professor Paul Vogt MD, at Zurich University Hospital, emerged from numerous contacts being made with Asian heart surgeons at the beginning of 2000, and consequent invitations to perform surgery and lecture tours in China.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
27 EU countries were represented in at least one of the eight short-listed entries for this award.
Dynamic mattresses, also called alternating air pressure mattresses or replacement mattress systems, have air cells that alternately inflate and deflate in a cycle to relieve pressure on the body.
Currently, early detection of Prostate Cancer depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. The prostate-cancer-gene-3 (PCA3) test is a new PCa gene-based marker carried out with a urine sample.
Tumour ablation - and Radiofrequency (RF) ablation in particular - is getting more and more important in oncology. The therapy option offers benefits in terms of costs, ease of set-up and flexibility so that experts see the need to expand the applications of it.
The number 1 fair for people with special needs, those requiring care and the chronically ill the REHACARE 2008, takes place from 15 to 18 October, Halls 3 to 7 of the Düsseldorf Trade Fair.The event will host 800 exhibitors from 30 countries presenting assistive devices and services to facilitate independent living.
Bis zu 92 Prozent der so Behandelten erleben eine deutliche Beschwerden-Linderung durch die rückenmarksnahe Applizierung von Baclofen mittels einer implantierten Pumpe von Medtronic.
The UK's National Health Service is notorious for its waiting time for surgery. The Scottish Government recently decided to tackle this issue and proposed a Patient Rights Bill which includes a legal right to surgery within twelve weeks .
A hearing test screening, designed to detect hearing impairments in newborns, shell help prevent irreversible and permanent hearing problems in about 2000 babies in Germany per year. From 1 January 2009, this test might be covered by the statutory health insurances
Researchers have discovered a potential new treatment for diabetes by isolating and killing defective cells which prevent the natural production of insulin. The investigation opens the door to a potential therapy for patients with type 1 diabetes.
ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
Researchers at Linköping University and Uppsala University in Sweden can show that accumulation of protein aggregatess, amyloid, in the transplanted cells may be causing their death. With the aid of their results, physicians can enhance survival of islets transplants and improve treatment of type 1 diabetes.
Approximately 31 million people in the European Union are suffering from diabetes, a devastating disease with severe consequences for patients and their families, but also for the society at large and the economic prosperity of Europe. This week EH Online will focus on innovative strategies in diabetes care and on new management systems to support physicians and patients alike. Moreover, we will…
Transition Therapeutics Inc. announced that the first patient has been dosed in a Phase 2 clinical study of gastrin analogue, TT-223, in patients with type 2 diabetes. Gastrin based therapies are an emerging class of potential disease-modifying treatments for patients with diabetes.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
The German Federal Ministry of Education and Research recently agreed funding for a diabetes competence network — the first diabetes mellitus project to be funded by the ministry's new “Health Research — Research for People” programme.
